BA-1049

N/A

Report date: 2023/03/27 15:17:27
NME

Base Information

Drug NameBA-1049
Drug Alias NameBA-1049NRL-1049
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsHemangioma, Cavernous, Central Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioaxone
China Registration ClassN/A

Develop Information

Active CompaniesBioaxoneNeurelis Inc
Inactive CompaniesN/A
Active IndicationsHemangioma, Cavernous, Central Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A